ViewRay
VerifiedAdvanced radiation therapy technology for the treatment of cancer.
Launch date
Employees
Market cap
$975
Net debt
$151
Enterprise valuation
$824 (Public information from Aug 2023)
Share price
$0.025 VRAY
Oakwood Ohio (HQ)
| USD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 138 % | 9 % | (35 %) | 23 % | 46 % | 32 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (135 %) | (83 %) | (123 %) | (174 %) | (140 %) | (98 %) | (70 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (212 %) | (94 %) | (136 %) | (189 %) | (157 %) | (105 %) | (68 %) |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor investor investor investor investor investor investor investor investor | $0.0 | round |
| N/A | $0.0 | round | |
| N/A | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| N/A | $0.0 | round | |
* | $125m | Post IPO Debt | |
| Total Funding | 000k | ||
Related Content
Recent News about ViewRay
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.